Chen et al. discovered that via the ROS accumulation and the AKT pathway, the modulation of G6PD influenced bladder cancer, and high expression value of G6PD was a poor prognostic factor in BLCA [43]. Here, G6PD is linked to bladder transitional cell carcinoma.